Study on Retrolaminar Block's Impact on Opioid Use in Spine Surgery
A randomized controlled trial is evaluating the effectiveness of retrolaminar block in reducing opioid consumption post-lumbar spine fusion.
Phase III
Pain Management / Anesthesia
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The ongoing trial on retrolaminar block could significantly influence pain management practices in spine surgery, particularly in reducing opioid reliance. Successful outcomes may lead to a paradigm shift in postoperative care and recovery protocols, impacting both clinical practices and market dynamics.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor results on opioid consumption and recovery metrics post-trial completion for insights into clinical practice changes.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.